Is AI drug discovery and development finally here?

Impossible d'ajouter des articles

Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.

Veuillez réessayer plus tard

Échec de l’élimination de la liste d'envies.

Veuillez réessayer plus tard

Impossible de suivre le podcast

Impossible de ne plus suivre le podcast

Is AI drug discovery and development finally here?

Écouter gratuitement

Voir les détails

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.

In this episode of Our Own Devices, our host Nandagopal Rajan, CEO, The Indian Express Digital is joined by serial entrepreneur Soujanya Bhumkar, and Ritu Lal, CEO and Co-founder, GEn1E Lifesciences Inc. Today's conversation centres around using AI for discovering and developing drugs at a fast pace. As far as the field of biotechnology is concerned, a major use case for artificial intelligence is discovering and developing personalised drugs that can help solve more specific conditions and diseases, or specified strains of different illnesses. To learn more about how this is being done, tune into Our Own Devices with Nandagopal Rajan.

Produced by Niharika Nanda
Edited and mixed by Suresh Pawar

Aucun commentaire pour le moment